Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.

Source:http://linkedlifedata.com/resource/pubmed/id/11809699

Cancer Res. 2002 Jan 15 62 2 480-7

Download in:

View as

General Info

PMID
11809699